A resource for the culture and surface multiplication of human autologous fibroblasts on a collagen membrane carrier has obtained a national and international patent registered with the European Patent Office. It is an invention created thanks to the cooperation of the Scientists of the Silesian Medical University: Arkadiusz Dziedzic, MD, PhD; Robert Wojtyczka, MD; Robert Kubina, MD; Marta Tanasiewicz, MD; Prof. Ewa Talik from the University of Silesia; and Magdalena Skonieczny, MD, from the Silesian University of Technology in Gliwice.
What is the innovation of the invention according to the researchers? Increasingly, cells taken from the patient are being used for treatment requiring tissue restoration, with the possibility of using this technique in interventional dentistry, dental surgery and periodontics. As Dr. Dziedzic explains, the cell multiplication system consists of compartments separated by lockable apertures, with a collagen membrane inside. The reservoir contains a liquid medium with the patient's cells, stimulating fibroblast proliferation on a membrane carrier. The whole is protected by a microbial filter to prevent contamination. The modular design makes it easy to modify or control the culture process. It adds: - The device's simplified design makes it possible to use the reservoir in treatment rooms, in cooperation with a specialized laboratory. The invention has been nominated in the Eureka 2023 competition.
The interdisciplinary team of co-authors of the invention has expertise in cell culture, biotechnology and biomedical innovation.
